Product Information |
Product name |
Tauroursodeoxycholic acid; TUDCA |
CAS No. |
14605-22-2 |
Molecular Formula |
C26H49NO8S |
Molecular Weight |
499.712 |
Molecular Structure |
|
Quality Standard |
98% up by HPLC |
Appearance |
White crystals |
COA |
ANALYSIS |
SPECIFICATION |
RESULTS |
Appearance |
White crystals |
White crystals |
Specifies rotation |
+41°~+47° |
+46.3° |
Acidity(pH) |
1.3~2.3 |
2.0 |
Moisture |
6.5%~7.5% |
7.02% |
Sulphated ash |
≤ 0.1% |
0.04% |
Heavy metal |
≤ 20ppm |
< 20ppm |
Single impurity |
||
Ursodeoxycholic Acid |
≤ 0.5% |
Conforms |
Taurochenodeoxycholic acid |
≤ 0.8% |
0.01 |
Other Impurity |
≤ 0.4% |
Conforms |
Total of Other Impurity |
≤ 1.0% |
Conforms |
Assay (by HPLC) |
≥ 98% |
99.7% |
Conclusion |
CONFORM TO THE REQUIREMENT OF STANDARD |
Usage |
What is Tauroursodeoxycholic acid?
Tauroursodeoxycholic acid[TUDCA], the more hydrophilic form of ursodeoxycholic acid[UDCA], is the more abundant naturally produced bile acid in humans. Moreover, tauroursodeoxycholic acid is found in bears with high amount and has been used for centuries as a natural remedy in some Asian countries. It has been approved in Italy and Turkey for the treatment of cholesterol gallstones and as well as being investigational drug in China, Unites States, and Italy. Tauroursodeoxycholic acid is also under investigation of its potential therapeutic effects on Primary Biliary Cirrhosis[PBC], insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis.
*Products under the patent are only for R&D use